GEODE CAPITAL MANAGEMENT, LLC
Position in RCKT — Rocket Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in RCKT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,837,535
+$395,392 QoQ
Shares Held
2,189,256
+3.3% QoQ
Ownership
2.00%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. RCKT ranks #183 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in RCKT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,837,535 | 2,189,256 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,442,143 | 2,120,269 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $6,241,446 | 1,914,554 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,975,682 | 2,030,891 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $13,300,273 | 1,994,044 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $22,034,894 | 1,752,975 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $29,881,984 | 1,617,866 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $34,525,722 | 1,603,610 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $40,479,693 | 1,502,587 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $43,673,782 | 1,457,250 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $25,410,878 | 1,240,160 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $23,528,126 | 1,184,103 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $19,797,809 | 1,155,739 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $21,552,832 | 1,101,320 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $13,713,135 | 859,219 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,124,450 | 808,463 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $11,874,968 | 748,737 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $16,473,507 | 754,627 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $22,473,125 | 751,861 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $32,858,175 | 741,887 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $30,455,079 | 686,389 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $32,939,097 | 600,640 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $12,139,391 | 531,032 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $11,491,574 | 549,048 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $7,246,411 | 519,456 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||